Cytosorbents (CTSO) Non-Current Assets (2010 - 2026)
Cytosorbents' (CTSO) quarterly Non-Current Assets came in at $22.8 million in Q1 2026, down 10.11% YoY from $25.4 million in Q1 2025, and down 3.16% on a QoQ basis from $23.5 million in Q4 2025.
Cytosorbents (CTSO) Non-Current Assets (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Non-Current Assets data on file, last reported at $22.8 million in Q1 2026.
- Quarterly Non-Current Assets fell 10.11% year-over-year to $22.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.8 million (down 15.83% YoY) and the FY2025 annual result came in at $23.5 million, down 8.62% from the prior year.
- Non-Current Assets slipped to $22.8 million in Q1 2026, from $23.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $31.5 million in Q2 2024 to a low of $22.8 million in Q1 2026.
- A 5-year average of $27.5 million and a median of $27.6 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets jumped 249.53% — and 2025, when it declined 21.69%.
- Tracing CTSO's Non-Current Assets over 5 years: stood at $29.5 million in 2022, then slipped by 6.49% to $27.6 million in 2023, then fell by 6.49% to $25.8 million in 2024, then slipped by 8.62% to $23.5 million in 2025, then retreated by 3.16% to $22.8 million in 2026.
- The last three Non-Current Assets figures came in at $22.8 million (Q1 2026), $23.5 million (Q4 2025), and $24.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 22.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.22 Mn |
| Mar 31, 2026 | 22.81 Mn |
| Dec 31, 2025 | 23.55 Mn |
| Sep 30, 2025 | 24.44 Mn |
| Jun 30, 2025 | 25.00 Mn |
| Mar 31, 2025 | 25.37 Mn |
| Dec 31, 2024 | 25.77 Mn |
| Sep 30, 2024 | 31.21 Mn |
| Jun 30, 2024 | 31.47 Mn |
| Mar 31, 2024 | 27.08 Mn |
| Dec 31, 2023 | 27.56 Mn |
| Sep 30, 2023 | 28.31 Mn |
| Jun 30, 2023 | 28.80 Mn |
| Mar 31, 2023 | 29.30 Mn |
| Dec 31, 2022 | 29.47 Mn |
| Sep 30, 2022 | 29.89 Mn |
| Jun 30, 2022 | 29.56 Mn |
| Mar 31, 2022 | 27.42 Mn |
| Dec 31, 2021 | 25.22 Mn |
| Sep 30, 2021 | 22.32 Mn |